Literature DB >> 3147006

Transient impaired glucose tolerance in Pima Indians: is it important?

M F Saad1, W C Knowler, D J Pettitt, R G Nelson, P H Bennett.   

Abstract

As part of a continuing epidemiological study of non-insulin dependent diabetes among Pima Indians 154 subjects who had had a transient impairment of glucose tolerance were followed up for 1.2-16.9 (median 5.8) years after their glucose tolerance had returned to normal. Of these, 49 subsequently developed diabetes; 26 subsequently developed impaired glucose tolerance; and 79 had normal glucose tolerance at the last examination. The cumulative incidence of diabetes was 16% and 48% at five and 10 years of follow up respectively, compared with 3% and 8% for a control group of 1245 members of the same population. After adjustment for age, sex, body mass index, and plasma glucose concentration two hours after glucose loading the incidence of diabetes among the subjects who had had transient impaired glucose tolerance was 3.0 times that among the controls (95% confidence interval 2.1 to 4.3). Proportional hazards function analysis indicated that obesity was the most important predictor of subsequent development of diabetes. The results suggest that transient impairment of glucose tolerance indicates, at least in some subjects, a predisposition to diabetes and should not be considered clinically unimportant.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3147006      PMCID: PMC1835114          DOI: 10.1136/bmj.297.6661.1438

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  16 in total

1.  Insulin and glucose responses to identical oral glucose tolerance tests performed forty-eight hours apart.

Authors:  J M Olefsky; G M Reaven
Journal:  Diabetes       Date:  1974-05       Impact factor: 9.461

2.  Do we need IGT?

Authors:  R J Jarrett
Journal:  Diabet Med       Date:  1987 Nov-Dec       Impact factor: 4.359

3.  Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation.

Authors:  G Sartor; B Scherstén; S Carlström; A Melander; A Nordén; G Persson
Journal:  Diabetes       Date:  1980-01       Impact factor: 9.461

4.  Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests.

Authors:  O P Ganda; J L Day; J S Soeldner; J J Connon; R E Gleason
Journal:  Diabetes       Date:  1978-07       Impact factor: 9.461

5.  In vitro insensitivity of glucose transport and antilipolysis to insulin due to receptor and postreceptor abnormalities in obese Pima Indians with normal glucose tolerance.

Authors:  A Kashiwagi; C Bogardus; S Lillioja; T P Huecksteadt; D Brady; M A Verso; J E Foley
Journal:  Metabolism       Date:  1984-08       Impact factor: 8.694

6.  Reproducibility of the new diagnostic criteria for impaired glucose tolerance.

Authors:  G Riccardi; O Vaccaro; A Rivellese; S Pignalosa; L Tutino; M Mancini
Journal:  Am J Epidemiol       Date:  1985-03       Impact factor: 4.897

7.  The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes.

Authors:  H Keen; R J Jarrett; P McCartney
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

8.  Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota.

Authors:  W C Knowler; P H Bennett; R F Hamman; M Miller
Journal:  Am J Epidemiol       Date:  1978-12       Impact factor: 4.897

9.  Diabetes incidence in Pima indians: contributions of obesity and parental diabetes.

Authors:  W C Knowler; D J Pettitt; P J Savage; P H Bennett
Journal:  Am J Epidemiol       Date:  1981-02       Impact factor: 4.897

10.  Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: The Framingham Study.

Authors:  P W Wilson; D L McGee; W B Kannel
Journal:  Am J Epidemiol       Date:  1981-11       Impact factor: 4.897

View more
  8 in total

1.  The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.

Authors: 
Journal:  Diabetes Care       Date:  2000-11       Impact factor: 19.112

Review 2.  Impaired glucose tolerance.

Authors:  J S Yudkin; K G Alberti; D G McLarty; A B Swai
Journal:  BMJ       Date:  1990-09-01

3.  Interpreting laboratory results.

Authors:  D R Karnad
Journal:  BMJ       Date:  1989-08-05

4.  Impaired glucose tolerance.

Authors:  M J Davies; I P Gray
Journal:  BMJ       Date:  1996-02-03

5.  Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.

Authors:  Leigh Perreault; Qing Pan; Kieren J Mather; Karol E Watson; Richard F Hamman; Steven E Kahn
Journal:  Lancet       Date:  2012-06-09       Impact factor: 79.321

6.  Glucose challenge test screening for prediabetes and early diabetes.

Authors:  S L Jackson; S E Safo; L R Staimez; D E Olson; K M V Narayan; Q Long; J Lipscomb; M K Rhee; P W F Wilson; A M Tomolo; L S Phillips
Journal:  Diabet Med       Date:  2016-11-02       Impact factor: 4.359

7.  Early and late insulin response as predictors of NIDDM in Pima Indians with impaired glucose tolerance.

Authors:  D K Nagi; W C Knowler; M A Charles; Q Z Liu; R L Hanson; D R McCance; D J Pettitt; P H Bennett
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

8.  Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS).

Authors:  Leigh Perreault; Qing Pan; Emily B Schroeder; Rita R Kalyani; George A Bray; Samuel Dagogo-Jack; Neil H White; Ronald B Goldberg; Steven E Kahn; William C Knowler; Nestoras Mathioudakis; Dana Dabelea
Journal:  Diabetes Care       Date:  2019-07-18       Impact factor: 19.112

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.